Login
Toggle navigation
Videos
Categories
Trending
Barret Esophagus Screening - Dr Kornpong Vantanasiri, Mayo Clinic
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Dr Kornpong Vantanasiri on Barret Esophagus Screening
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Journey to Business is shaky|Apoorva Goyal,Vice President,Insight Partners
00:10:00
"Impactful Ownership: Nathan Cockrell's Leadership in Purposeful ESG Engagements"
00:10:00
Karim Awad on EFG Hermes' Acquisition of 51% Stake in AIB and Transformation to Universal Bank | Karim Awad , CEO, Egypt EFG Hermes.
00:10:00
Exploiting Vanadium Opportunities in Scandinavia: Pursuit Minerals' Advanced Projects
00:10:00
CMC Metals Targets High-Grade Silver-Lead-Zinc Deposits in Yukon and Northern BC
00:10:00
Learn about Pictet Asset Management USA from its CEO, Elizabeth Dillon, and delve deeper into our offerings on our website.
00:10:00
The Impact of Prolonged Low Interest Rates on the Market | Morgan Christen, CEO, Spinnaker Investment Group, LLC.
00:10:00
Bluenord ASA stands as a pioneer in the development and implementation of renewable energy solutio|EUAN SHIRLAW. , CHIEF EXECUTIVE OFFICER AT BLUENORD AS
00:10:00
building deep tech companies powered by material science innovations|Carmichael Roberts,Managing Partner,Material Impact Fund
00:10:00
Asia Beckons: Limited Partners Eye High Returns in Private Equity Amidst Global Financial Turmoil|Doug Coulter,partner,LGTCapital
00:10:00
Dan Betts, Executive Chairman and CEO of Hummingbird Resources, discusses the company's journey from grassroots exploration to a listed, producing mining company with gold projects in Mali and Guinea, emphasizing their rich history in the precious metals
00:10:00
Insights into Global Financial Markets: 2024 Outlook on Stocks, Inflation, and Interest Rates